The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis
Open accessAbstract
Similar to macrophages, microglia adopt diverse activation states and contribute to repair and tissue damage in multiple sclerosis. Using reverse transcription-quantitative polymerase chain reaction and immunohistochemistry, we show that in vitro M1-polarized (proinflammatory) human adult microglia express the distinctive markers CD74, CD40, CD86, and CCR7, whereas M2 (anti-inflammatory) microglia express mannose receptor and the anti-inflammatory cytokine CCL22. The expression of these markers was assessed in clusters of activated microglia in normal-appearing white matter (preactive lesions) and areas of remyelination, representing reparative multiple sclerosis lesions. We show that activated microglia in preactive and remyelinating lesions express CD74, CD40, CD86, and the M2 markers CCL22 and CD209, but not mannose receptor. To examine whether this intermediate microglia profile is static or dynamic and thus susceptible to changes in the microenvironment, we polarized microglia into M1 or M2 phenotype in vitro and then subsequently treated them with the opposing polarization regimen. These studies revealed that expression of CD40, CXCL10, and mannose receptor is dynamic and that microglia, like macrophages, can switch between M1 and M2 phenotypic profiles. Taken together, our data define the differential activation states of microglia during lesion development in multiple sclerosis-affected CNS tissues and underscore the plasticity of human adult microglia in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Here, we show that the increased TSPO expression in multiple sclerosis lesions primarily represents an intermediate activation state in which cells expressed both CD40 and CD206 (Vogel et al., 2013; Peferoen et al., 2015); microglia solely expressing the pro-inflammatory marker CD40 or the anti-inflammatory marker mannose receptor CD206 were sparsely represented.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Peferoen et al., 2015
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, microglia/macrophages in multiple sclerosis lesions adopt an intermediate phenotype, and the classical M1 (pro-inflammatory) and M2 (anti-inflammatory) phenotypes probably represent extreme states only found in vitro (Peferoen et al., 2015).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Peferoen et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Here, we show that the increased TSPO expression in multiple sclerosis lesions primarily represents an intermediate activation state in which cells expressed both CD40 and CD206 (Vogel et al., 2013; Peferoen et al., 2015); microglia solely expressing the pro-inflammatory marker CD40 or the anti-inflammatory marker mannose receptor CD206 were sparsely represented.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Peferoen et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
Ruijter, J. M., Ramakers, C., Hoogaars, W. M. H., Karlen, Y., Bakker, O., van den Hoff, M. J. B., & Moorman, A. F. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp045 · Cited by 3,043
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Repertoire of microglial and macrophage responses after spinal cord injury
David, S., & Kroner, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3053 · Cited by 1,297
Microglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061
Review: Activation patterns of microglia and their identification in the human brain
Boche, D., Perry, V. H., & Nicoll, J. A. R. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12011 · Cited by 955
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Gavet, O., & Pines, J. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.013 · Cited by 849
Macrophage activation switching: an asset for the resolution of inflammation
Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., Dormont, D., & Gras, G. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02934.x · Cited by 840
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 759
Chhor, V., Charpentier, T. L., Lebon, S., Oré, M. V., Lara‐Celador, I., Josserand, J., Degos, V., Jacotot, E. D., Hagberg, H., Sävman, K., et al. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.02.005 · Cited by 676
Zeyda, M., Farmer, D., Todoric, J., Aszmann, O. C., Speiser, M., Györi, G., Zlabinger, G. J., & Stulnig, T. M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803632 · Cited by 553
Jaguin, M., Houlbert, N., Fardel, O., & Lecureur, V. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.01.010 · Cited by 547
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479
Self-citationComparison of polarization properties of human adult microglia and blood‐derived macrophages
Durafourt, B. A., Moore, C. S., Zammit, D., Johnson, T., Zaguia, F., Guiot, M., Bar‐Or, A., & Antel, J. P. (2012) · Glia · doi:10.1002/glia.22298 · Cited by 470
Human macrophage polarization in vitro: maturation and activation methods compared.
Vogel, D., Glim, J. E., Stavenuiter, A. W., Breur, M., Heijnen, P., Amor, S., Dijkstra, C., & Beelen, R. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.05.002 · Cited by 431
Self-citationVarnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 412
Systematic validation of specific phenotypic markers for in vitro polarized human macrophages
Ambarus, C. A., Krausz, S., van Eijk, M., Hamann, J., Radstake, T. R. D. J., Reedquist, K. A., Tak, P. P., & Baeten, D. L. P. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.10.013 · Cited by 411
Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions
Henderson, A. P. D., Barnett, M. H., Parratt, J. D. E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21800 · Cited by 403
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., & Franklin, R. J. M. (2001) · Glia · doi:10.1002/glia.1085 · Cited by 385
Mice lacking the MHC class II-associated invariant chain
Viville, S., Neefjes, J., Lotteau, V., Dierich, A., LeMeur, M., Ploegh, H. L., Benoist, C. O., & Mathis, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90081-z · Cited by 374
Identification of a microglia phenotype supportive of remyelination
Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., & Boddeke, H. W. G. M. (2012) · Glia · doi:10.1002/glia.21266 · Cited by 358
Self-citationMikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B., Canron, M.-H., Franconi, J.-M., Boiziau, C., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510379243 · Cited by 358
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353
Self-citationMizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., & Cardona, A. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100421 · Cited by 346
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.019 · Cited by 331
Groot, C. J. A. D. (2001) · Brain · doi:10.1093/brain/124.8.1635 · Cited by 285
Expression of CCR7 in multiple sclerosis: implications for CNS immunity
Kivisäkk, P., Mahad, D. J., Callahan, M. K., Sikora, K., Trebst, C., Tucky, B., Wujek, J., Ravid, R., Staugaitis, S. M., Lassmann, H., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20049 · Cited by 267
Butovsky, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26836 · Cited by 261
Olah, M., Biber, K. P. H., Vinet, J., & Boddeke, H. W. G. M. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794488575 · Cited by 260
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
Ghebremedhin, E., Tredici, K. D., Vukšić, M., Rüb, U., Thal, D. R., Burbach, G. J., Rosenberger, A., Bickeböller, H., Deller, T., de Vos, R. A. I., et al. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000199572.96472.1c · Cited by 238
Fabriek, B. O., van Haastert, E. S., Galea, I., Polfliet, M. M. J., Döpp, E. A., van den Heuvel, M. M., van den Berg, T. K., Groot, C. J. A. D., van der Valk, P., & Dijkstra, C. D. (2005) · Glia · doi:10.1002/glia.20208 · Cited by 218
Self-citationThe benefits and detriments of macrophages/microglia in models of multiple sclerosis
Rawji, K. S., & Yong, V. W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/948976 · Cited by 217
Zeis, T., Graumann, U., Reynolds, R., & Schaeren‐Wiemers, N. (2007) · Brain · doi:10.1093/brain/awm291 · Cited by 214
Qin, H., Wilson, C. A., Lee, S. J., Zhao, X., & Benveniste, E. N. (2005) · Blood · doi:10.1182/blood-2005-02-0759 · Cited by 205
Voß, E. V., Škuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., & Stangel, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.008 · Cited by 202
Remyelination in multiple sclerosis
Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191
Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation
Vogel, D. Y. S., Heijnen, P. D. A. M., Breur, M., de Vries, H. E., Tool, A. T. J., Amor, S., & Dijkstra, C. D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-23 · Cited by 186
Self-citationvan Horssen, J., Singh, S., van der Pol, S., Kipp, M., Lim, J. L., Peferoen, L., Gerritsen, W., Kooi, E.-J., Witte, M. E., Geurts, J. J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-156 · Cited by 172
Self-citationC3-dependent mechanism of microglial priming relevant to multiple sclerosis
Ramaglia, V., Hughes, T. R., Donev, R., Ruseva, M. M., Wu, X., Huitinga, I., Baas, F., Neal, J., & Morgan, B. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111924109 · Cited by 157
Preactive lesions in multiple sclerosis
van der Valk, P., & Amor, S. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4c76 · Cited by 156
Self-citationPhenotyping primary human microglia: tight regulation of LPS responsiveness
Melief, J., Koning, N., Schuurman, K. G., Van De Garde, M. D. B., Smolders, J., Hoek, R. M., Van Eijk, M., Hamann, J., & Huitinga, I. (2012) · Glia · doi:10.1002/glia.22370 · Cited by 146
Hulshof, S. C. J., Montagne, L., Groot, C. J. A. D., & van der Valk, P. (2002) · Glia · doi:10.1002/glia.10050 · Cited by 140
Regulation of Macrophage-Derived Chemokine (MDC/ CCL22) Production
Yamashita, U., & Kuroda, E. (2002) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v22.i2.10 · Cited by 137
Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
Zhang, Z., Zhang, Z., Schittenhelm, J., Wu, Y., Meyermann, R., & Schluesener, H. J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.006 · Cited by 124
Microglial polarization and plasticity: Evidence from organotypic hippocampal slice cultures
Ajmone‐Cat, M. A., Mancini, M., Simone, R. D., Cilli, P., & Minghetti, L. (2013) · Glia · doi:10.1002/glia.22550 · Cited by 114
van Noort, J. M., Bsibsi, M., Gerritsen, W. H., van der Valk, P., Bajramovic, J. J., Steinman, L., & Amor, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e4939c · Cited by 112
Self-citationGarcía-Vallejo, J. J., Ilarregui, J. M., Kalay, H., Chamorro, S., Koning, N., Unger, W. W. J., Ambrosini, M., Montserrat, V., Fernandes, R. J., Bruijns, S. C. M., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20122192 · Cited by 110
Self-citationCan we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & de Rosbo, N. K. (2013) · Immunology · doi:10.1111/imm.12177 · Cited by 87
Bsibsi, M., Peferoen, L., Holtman, I., Nacken, P., Gerritsen, W., Witte, M., van Horssen, J., Eggen, B., van der Valk, P., Amor, S., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1317-8 · Cited by 87
Self-citationZhang, X., Lund, H., Mia, S., Parsa, R., & Harris, R. A. (2014) · Glia · doi:10.1002/glia.22643 · Cited by 78
Zeis, T., Probst, A., Steck, A. J., Stadelmann, C., Brück, W., & Schaeren‐Wiemers, N. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00231.x · Cited by 76
Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed
Melief, J., Schuurman, K. G., van de Garde, M. D. B., Smolders, J., van Eijk, M., Hamann, J., & Huitinga, I. (2013) · Glia · doi:10.1002/glia.22562 · Cited by 56
Meza‐Romero, R., Benedek, G., Yu, X., Mooney, J. L., Dahan, R., Duvshani, N., Bucala, R., Offner, H., Reiter, Y., Burrows, G. G., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303118 · Cited by 54
Partial MHC class II constructs inhibit MIF / CD 74 binding and downstream effects
Benedek, G., Meza‐Romero, R., Andrew, S. F., Leng, L., Burrows, G. G., BOURDETTE, D. N., Offner, H., Bucala, R., & Vandenbark, A. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201243162 · Cited by 53
Bsibsi, M., Holtman, I. R., Gerritsen, W. H., Eggen, B. J. L., Boddeke, E., van der Valk, P., van Noort, J. M., & Amor, S. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182a776bf · Cited by 44
Self-citationAbundant extracellular myelin in the meninges of patients with multiple sclerosis
Kooi, E., van Horssen, J., Witte, M. E., Amor, S., Bø, L., Dijkstra, C. D., van der Valk, P., & Geurts, J. J. G. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00986.x · Cited by 43
Self-citationDendritic cells are abundant in non-lesional gray matter in multiple sclerosis
Cudrici, C. D., Ito, T., Zafranskaia, E., Niculescu, F. I., Mullen, K. M., Vlaicu, S. I., Judge, S. I. V., Calabresi, P. A., & Rus, H. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.05.006 · Cited by 28
MDC/CCL22 intrathecal levels in patients with multiple sclerosis
Galimberti, D., Fenoglio, C., Comi, C., Scalabrini, D., Riz, M. A. D., Leone, M. A., Venturelli, E., Cortini, F., Piola, M., Monaco, F., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507084268 · Cited by 26
Expression of Chemokine Receptors CCR7 and CCR8 in the CNS During ChREAE
Bielecki, B., Mazurek, A., Woliński, P., & Glabinski, A. R. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01954.x · Cited by 22
Zhang, H., Liu, C., Cheng, S., Wang, X., Li, W., Charreyre, C., Audonnet, J. C., & He, Q. (2013) · Archives of Virology · doi:10.1007/s00705-013-1750-3 · Cited by 20
Research works printed but not linked: 1
- 10.1097/65.2.124 · DOI
Cited by
Sorted by citations
Modulators of microglial activation and polarization after intracerebral haemorrhage
Lan, X., Han, X., Li, Q., Yang, Q.-W., & Wang, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.69 · Cited by 915
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684
Walker, D. G., & Lue, L.-F. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0139-9 · Cited by 562
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Dal-Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Höftberger, R., Berger, T., Auff, E., Leutmezer, F., Trattnig, S., Lassmann, H., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1636-z · Cited by 463
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 477
Metadata
- Authors
- Peferoen, L. A. N., Vogel, D. Y. S., Ummenthum, K., Breur, M., Heijnen, P. D. A. M., Gerritsen, W. H., Peferoen-Baert, R. M. B., van der Valk, P., Dijkstra, C. D., & Amor, S.
- Affiliations
- Queen Mary University of London (GB)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Amor, Sandra
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01
- Volume
- 74
- Issue
- 1
- Pages
- 48-63
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W2079198405
- Cited by
- 178
- References
- 66
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 10 · 2023: 11 · 2022: 19 · 2021: 11 · 2020: 18 · 2019: 24 · 2018: 13 · 2017: 17 · 2016: 26 · 2015: 15
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- microglial activation, multiple sclerosis, remyelination, macrophage polarization, microglial plasticity, CD40, CD74, CCL22, CD206, CD86, CXCL10, normal-appearing white matter, lesion progression, microglial markers
- MeSH terms
- Aged, Aged, 80 and over, Histocompatibility Antigens Class II, Brain, Cell Differentiation, Cells, Cultured, Female, Flow Cytometry, Humans, Macrophages, Male, Middle Aged, Multiple Sclerosis, RNA, Messenger, Antigens, CD, Cytokines, Microglia, Statistics, Nonparametric, Myelin Proteolipid Protein, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
